Starks Daniel J's Form 4 filing
Abbott Laboratories (ABT) · filed Jul 28, 2023
- Accession no.
- 0001415889-23-011571
- Filed
- Jul 28, 2023
- Trade date
- Jul 27, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.69M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Starks Daniel JCIK 0000902132 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2023 | Common shares without par value | SSaleDisposed | −20,934 | $113.43 | −$2,374,543.62 | 6,804,382 | Direct | |
| Jul 27, 2023 | Common shares without par value | SSaleDisposed | −29,066 | $114.01 | −$3,313,814.66 | 6,775,316 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.